Re: Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

被引:0
|
作者
Marks, Leonard S. [1 ]
Huang, Jiaoti
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
关键词
D O I
10.1016/j.eururo.2010.01.028
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:727 / 728
页数:2
相关论文
共 50 条
  • [41] EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment:a meta-analysis
    Wei-Dong Shen
    Hong-Lin Chen
    Peng-Fei Liu
    ChineseJournalofCancerResearch, 2014, 26 (01) : 59 - 71
  • [42] EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment: a meta-analysis
    Shen, Wei-Dong
    Chen, Hong-Lin
    Liu, Peng-Fei
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (01) : 59 - 71
  • [43] Integrated clinics whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
    Bova, G. Steven
    Kallio, Heini M. L.
    Annala, Matti
    Kivinummi, Kati
    Hognas, Gunilla
    Hayrynen, Sergei
    Rantapero, Tommi
    Kivinen, Virpi
    Isaacs, William B.
    Tolonen, Teemu
    Nykter, Matti
    Visakorpi, Tapio
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2016, 2 (03):
  • [44] Copy Number Analysis in Cancer Diagnostic Testing
    Spence, Tara
    Dubuc, Adrian M.
    CLINICS IN LABORATORY MEDICINE, 2022, 42 (03) : 451 - 468
  • [45] Copy number aberrations in prostate cancer cell lines by single nucleotide polymorphism array analysis
    Ricke, W. A.
    Lee, Y-F.
    Messing, E. M.
    Reeder, J. E.
    BJU INTERNATIONAL, 2007, 100 : 36 - 37
  • [46] Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
    Conteduca, Vincenza
    Ku, Sheng-Yu
    Fernandez, Luisa
    Dago-Rodriquez, Angel
    Lee, Jerry
    Jendrisak, Adam
    Slade, Megan
    Gilbertson, Cole
    Manohar, Jyothi
    Sigouros, Michael
    Wang, Yipeng
    Dittamore, Ryan
    Wenstrup, Rick
    Mosquera, Juan Miguel
    Schonhoft, Joseph D.
    Beltran, Himisha
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [47] ANALYSIS OF COPY NUMBER ABERRATION IN BREAST CANCER
    Taira, F.
    Takahashi, Y.
    Saito, M.
    Kanatani, A.
    Akashi, K.
    Ito, T.
    Murakami, Y.
    ANNALS OF ONCOLOGY, 2013, 24
  • [48] Clustering-Based Method for Developing a Genomic Copy Number Alteration Signature for Predicting the Metastatic Potential of Prostate Cancer
    Pearlman, Alexander
    Campbell, Christopher
    Brooks, Eric
    Genshaft, Alex
    Shajahan, Shahin
    Ittman, Michael
    Bova, G. Steven
    Melamed, Jonathan
    Holcomb, Ilona
    Schneider, Robert J.
    Ostrer, Harry
    JOURNAL OF PROBABILITY AND STATISTICS, 2012, 2012
  • [49] Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer
    Salvi, Samanta
    Casadio, Valentina
    Conteduca, Vincenza
    Lolli, Cristian
    Gurioli, Giorgia
    Martignano, Filippo
    Schepisi, Giuseppe
    Testoni, Sara
    Scarpi, Emanuela
    Amadori, Dino
    Calistri, Daniele
    Attard, Gerhardt
    De Giorgi, Ugo
    ONCOTARGET, 2016, 7 (25) : 37839 - 37845
  • [50] Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer
    Zhang, Yi
    Martens, John W. M.
    Yu, Jack X.
    Jiang, John
    Sieuwerts, Anieta M.
    Smid, Marcel
    Klijn, Jan G. M.
    Wang, Yixin
    Foekens, John A.
    CANCER RESEARCH, 2009, 69 (09) : 3795 - 3801